Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

HOMAPIN-5

HOMATROPINE METHYLBROMIDE

Standard Dose
5MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview HOMAPIN-5 is listed in Drugs@FDA under application 086309 (ANDA).

Marketing status: Discontinued Active ingredient HOMATROPINE METHYLBROMIDE Form and strength TABLET;ORAL - 5MG Sponsor MISSION PHARMA Submission history Latest submission status date: 1992-07-06 00:00:00.

Structured Monograph

Clinical summary

Approval overview HOMAPIN-5 is listed in Drugs@FDA under application 086309 (ANDA). Marketing status: Discontinued Active ingredient HOMATROPINE METHYLBROMIDE Form and strength TABLET;ORAL - 5MG Sponsor MISSION PHARMA Submission history Latest submission status date: 1992-07-06 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
HOMAPIN-5 (HOMATROPINE METHYLBROMIDE) | Drug Monograph | MedicHelpline